Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MFA
2926
MFA Financial
MFA
$921M
| $1.83M | ﹤0.01% |
162,274
+125,737
| +344% | +$1.27M |
|
2927
Cerence
CRNC
$412M
| $1.83M | ﹤0.01% |
92,830
+67,715
| +270% | +$1.18M |
|
|
CFLT
2928
PUT
DELISTED
Confluent
CFLT
| $1.82M | ﹤0.01% |
77,900
-204,500
| -72% | -$4.94M |
|
2929
CALL
Expedia Group
EXPE
$37.2B
| $1.82M | ﹤0.01% |
12,000
-988,000
| -99% | -$121M |
|
|
SAFE
2930
Safehold
SAFE
$1.11B
| $1.82M | ﹤0.01% |
77,694
+38,029
| +96% | +$717K |
|
2931
CALL
Dow Inc
DOW
$21.5B
| $1.81M | ﹤0.01% |
33,000
+25,000
| +313% | +$1.28M |
|
2932
Protolabs
PRLB
$2.14B
| $1.81M | ﹤0.01% |
46,443
+33,033
| +246% | +$1.07M |
|
|
PRSU
2933
Pursuit Attractions and Hospitality Inc
PRSU
$1.24B
| $1.81M | ﹤0.01% |
49,921
+27,750
| +125% | +$840K |
|
2934
Montauk Renewables
MNTK
$249M
| $1.81M | ﹤0.01% |
202,709
+144,846
| +250% | +$1.36M |
|
|
CDMO
2935
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.8M | ﹤0.01% |
277,317
+150,706
| +119% | +$971K |
|
2936
Barrett Business Services
BBSI
$790M
| $1.79M | ﹤0.01% |
61,988
+36,540
| +144% | +$942K |
|
2937
Archer Aviation
ACHR
$4.99B
| $1.79M | ﹤0.01% |
292,043
+241,484
| +478% | +$1.37M |
|
|
RNAM
2938
DELISTED
Avidity Biosciences
RNAM
| $1.79M | ﹤0.01% |
198,114
+8,794
| +5% | +$58.8K |
|
|
EVBG
2939
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $1.79M | ﹤0.01% |
73,732
+54,799
| +289% | +$1.18M |
|
2940
United Natural Foods
UNFI
$2.81B
| $1.79M | ﹤0.01% |
110,332
+65,150
| +144% | +$991K |
|
2941
FuboTV Inc
FUBO
$268M
| $1.79M | ﹤0.01% |
46,814
+29,833
| +176% | +$1.03M |
|
2942
AdvanSix
ASIX
$431M
| $1.79M | ﹤0.01% |
59,584
+26,231
| +79% | +$729K |
|
2943
CALL
Acadia Pharmaceuticals
ACAD
$5.09B
| $1.78M | ﹤0.01% |
+57,000
| New | +$1.36M |
|
|
2944
PUT
Acadia Pharmaceuticals
ACAD
$5.09B
| $1.78M | ﹤0.01% |
+57,000
| New | +$1.36M |
|
2945
Arlo Technologies
ARLO
$1.55B
| $1.78M | ﹤0.01% |
187,386
+122,892
| +191% | +$1.12M |
|
2946
Triple Flag Precious Metals
TFPM
$6.63B
| $1.78M | ﹤0.01% |
133,883
+10,880
| +9% | +$142K |
|
|
CSR
2947
Centerspace
CSR
$931M
| $1.78M | ﹤0.01% |
30,601
+17,771
| +139% | +$970K |
|
|
GDEN
2948
DELISTED
Golden Entertainment
GDEN
| $1.78M | ﹤0.01% |
44,468
+20,333
| +84% | +$737K |
|
|
CCRN
2949
DELISTED
Cross Country Healthcare
CCRN
| $1.77M | ﹤0.01% |
78,389
+35,126
| +81% | +$762K |
|
2950
Vital Farms
VITL
$506M
| $1.77M | ﹤0.01% |
113,071
+54,424
| +93% | +$688K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.